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Depression is currently the second largest contributor to non-fatal disease burden globally.
For that reason, economic evaluations are increasingly being conducted using data from
depression prevalence estimates to analyze return on investments for services that target
mental health. Psychiatric epidemiology studies have reported large cross-national differ-
ences in the prevalence of depression. These differences may impact the cost-effectiveness
assessments of mental health interventions, thereby affecting decisions regarding govern-
ment and multi-lateral investment in mental health services. Some portion of the differences
in prevalence estimates across countries may be due to true discrepancies in depression
prevalence, resulting from differential levels of risk in environmental and demographic fac-
tors. However, some portion of those differences may reflect non-invariance in the way stan-
dard tools measure depression across countries. This paper attempts to discern the extent
to which measurement differences are responsible for reported differences in the preva-
lence of depression across countries.
Methods and findings
This analysis uses data from the World Mental Health Surveys, a coordinated series of psy-
chiatric epidemiology studies in 27 countries using multistage household probability sam-
ples to assess prevalence and correlates of mental disorders. Data in the current study
include responses to the depression module of the World Mental Health Composite Interna-
tional Diagnostic Interview (CIDI) in four countries: Two high-income, western countries—
the United States (n = 20, 015) and New Zealand (n = 12,992)—an upper-middle income
sub-Saharan African country, South Africa (n = 4,351), and a lower-middle income sub-
Saharan African country, Nigeria (n = 6,752). Latent class analysis, a type of finite mixture
modeling, was used to categorize respondents into underlying categories based on the vari-
ation in their responses to questions in each of three sequential parts of the CIDI depression
module: 1) The initial screening items, 2) Additional duration and severity exclusion criteria,
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and 3) The core symptom questions. After each of these parts, exclusion criteria expel
respondents from the remainder of the diagnostic interview, rendering a diagnosis of “not
depressed”. Latent class models were fit to each of the three parts in each of the four coun-
tries, and model fit was assessed using overall chi-square values and Pearson standardized
residuals. Latent transition analysis was then applied in order to model participants’ progres-
sion through the CIDI depression module. Proportion of individuals falling into each latent
class and probabilities of transitioning into subsequent classes were used to estimate the
percentage in each country that ultimately fell into the more symptomatic class, i.e. classi-
fied as “depressed”. This latent variable design allows for a non-zero probability that individ-
uals were incorrectly excluded from or retained in the diagnostic interview at any of the three
exclusion points and therefore incorrectly diagnosed. Prevalence estimates based on the
latent transition model reversed the order of depression prevalence across countries. Based
on the latent transition model in this analysis, Nigeria has the highest prevalence (21.6%),
followed by New Zealand (17.4%), then South Africa (15.0%), and finally the US (12.5%).
That is compared to the estimates in the World Mental Health Surveys that do not allow for
measurement differences, in which Nigeria had by far the lowest prevalence (3.1%), fol-
lowed by South Africa (9.8%), then the United States (13.5%) and finally New Zealand
(17.8%). Individuals endorsing the screening questions in Nigeria and South Africa were
more likely to endorse more severe depression symptomology later in the module (i.e. they
had higher transition probabilities), suggesting that individuals in the two Western countries
may be more likely to endorse screening questions even when they don’t have as severe
symptoms. These differences narrow the range of depression prevalence between coun-
tries 14 percentage points in the original estimates to 6 percentage points in the estimate
taking account of measurement differences.
Conclusions
These data suggest fewer differences in cross-national prevalence of depression than previ-
ous estimates. Given that prevalence data are used to support key decisions regarding
resource-allocation for mental health services, more critical attention should be paid to dif-
ferences in the functioning of measurement across contexts and the impact these differ-
ences have on prevalence estimates. Future research should include qualitative methods
as well as external measures of disease severity, such as impairment, to assess how the
latent classes predict these external variables, to better understand the way that standard
tools estimate depression prevalence across contexts. Adjustments could then be made to
prevalence estimates used in cost-effectiveness analyses.
Introduction
Mental and substance use disorders are the leading cause of non-fatal disease burden globally
[1,2], and depression is the most prevalent mental disorder [3]. Increasingly, economic evalua-
tions are using data from prevalence estimates like the Global Burden of Disease (GBD) studies
to estimate return on investments for services that target mental health [4]. In order to provide
the most rigorous assessments, global prevalence estimates need to be as accurate as possible.
Cross-national studies have found large differences in estimated levels of depression between
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countries [5–7]. This could be due in part to environmental factors, including exposure to
stressors or traumatic events such as political repression, rapid cultural shifts, socioeconomic
deprivation and threat of violence [5]. However, some part of these differences are likely due
to variations in the performance of measurement tools, a possibility acknowledged in most
cross-national psychiatric epidemiologic studies [5,6,8,9] yet rarely explored. Methodological
sources of measurement differences include, but are not limited to, cross-national differences
in the expression of standard criteria and differences in the willingness of respondents to
admit depressive symptoms in an interview even if they actually do experience them [10].
The initial estimates for the 1993 GBD were strongly critiqued [11,12]—data from a num-
ber of unpublished studies were used, with information collected via personal communication,
and the WHO African region had extremely low coverage with data on only three out of 46
countries and those data based on small villages or towns with sample sizes less than 1000 [11].
Recent analysis have shown that heterogeneity in the data used to calculate the GBD statistics
account for over 50% of the variability in prevalence between studies [13]. In the most recent
revisions to the GBD study [14], a modeled estimation included improved data sources [15]. A
number of assumptions must be made when including these disparate data in models to arrive
at regional prevalence estimates, including how various studies with specific, non-representa-
tive populations are weighted; how studies that do not include point-prevalence are converted
to be included in the estimates, given that GBD estimates are based on point prevalence; and
how estimates from studies using screening tools instead of diagnostic tools are adjusted.
Because these assumptions are not explicit in the explication of the model estimates for
regional prevalence in the GBD [15], it is difficult to analyze the influence of measurement dif-
ferences on the actual prevalence estimates used to calculate the global burden of depression.
However, a very well planned and carefully coordinated cross-national study that provides
key sources for the GBD estimates—the World Mental Health (WMH) Survey Initiative—pro-
vides data that make such an analysis of measurement invariance possible. A surprising find-
ing in the WMH surveys was that Nigeria had an extremely low estimate of prevalence [16], a
finding that has caused researchers to question the validity of those data [17]. This paper uses
WMH survey data from Nigeria as well as South Africa—the only other sub-Saharan African
countries in the WMH surveys—in addition to two high-income western countries—the
United States and New Zealand, to examine measurement differences in the WMH Composite
International Diagnostic Interview (WMH CIDI) across countries. The analysis uses a latent
variable technique to allow for measurement error in the CIDI module, particularly in screen-
ing questions and exclusion criteria, and to quantify and compare that measurement error
across countries. In doing so we provide an estimate of the impact of these measurement dif-
ferences on cross-country depression prevalence estimates.
Methods
Data/Sample
The WMH CIDI is an adaptation of the World Health Organization (WHO) CIDI for use in
WHO’s WMH surveys [18] in 27 countries. Principal investigators from South Africa and
Nigeria granted access to the WMH datasets from those countries. World Mental Health Sur-
vey data from the United States and New Zealand are publically accessible. The samples from
these four countries are described below.
South Africa
The South African Stress and Health Study (SASHS), which was the South African component
of the WMH surveys, used a national probability sample of 4,351 South African adults [19].
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Individuals of all race and ethnic backgrounds were included in the study. The sample was
selected using a three-stage clustered area probability sample design. The first stage involved
the selection of stratified primary sample areas based on the 2001 South African Census Enu-
meration Areas (EAs). The second stage involved the sampling of housing units within clusters
selected within each EA. The third stage involved the random selection of one adult respon-
dent in each sampled housing unit. Further sampling details are described in Williams et al.
2004 [20]. Overall response rate was 85.5%.
Nigeria
The Nigerian Survey of Mental Health and Well-being used a four-stage area probability sam-
ple of adults in households in 21 of Nigeria’s 36 states, representing about 57% of the national
population. A detailed description of the sampling procedure can be found in Gureje et al.
2006 [21]. In brief, the first stage consisted of sampling 40 local government areas; the second
stage selected four census enumeration areas from each primary sampling unit; in the third
stage, households were randomly selected from census enumeration areas; and in the fourth
stage, a probability procedure was used to select one respondent per household. The surveys
were conducted in Yoruba, Igbo, Hausa and Efik languages. Face-to-face interviews were car-
ried out on 6,752 respondents. The overall response rate was 79.3% [16].
New Zealand
The New Zealand Mental Health Survey, New Zealand’s contribution to the WMH surveys,
used a nationally representative sample of 12,992 adults living in permanent private dwellings
throughout New Zealand. The response rate was 73.3% [22]. Stratified sampling was used
wherein census blocks were selected as primary sampling units from within geographic strata.
Households were then systematically selected within census blocks, and one person was
selected from each dwelling using a Kish grid. The survey design is described in detail in Wells
et al. 2006 [23].
United States
The US data for the WMH surveys come from the Collaborative Psychiatric Epidemiology
Surveys [24], which comprise three separate surveys, the National Comorbidity Survey Repli-
cation, the National Survey of American Life, and the National Latino and Asian American
Study. The sample for all three surveys consisted of primary sampling units selected with prob-
abilities proportional to size. Response rates for the three surveys were 70.9%, 71.5%, and
75.7% respectively. Interviews were conducted as computer-assisted personal interviews, com-
puter-assisted telephone interviews, and telephone interviews. Data collection for the three
surveys was conducted in a total of 252 geographic areas or primary sampling units across the
United States. Total sample size was 20,015.
Standardized procedures for interviewer training, translation of study materials and quality
control were consistently used in each country of the World Mental Health Surveys [25].
Included in this analysis are three dichotomous depression screening items at the beginning
of the CIDI that determine whether individuals will be administered the CIDI depression
module, as well as all items in the WMH CIDI that are utilized in the DSM-based algorithm
for diagnosing depression. Screening questions and CIDI depression module questions were
combined into 18 variables, and these variables were divided into three parts based on the
points in the module at which large percentages of respondents were excluded from the rest of
the module. Fig 1 shows the three parts, and more detailed information is available in S1 File.
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Analysis
Latent class models were fit to each of the three parts of the CIDI depression model in each of
the four countries. Latent transition analysis was then applied to model participants’ progres-
sion through the CIDI depression model and to estimate the percentage in each country that
are classified as “depressed”.
Latent class models
Latent class analysis (LCA), a type of finite mixture modeling, categorizes respondents into
underlying categories (in this case, depressed or not depressed) based on the variation in their
responses to questions (in this case the CIDI depression items). A detailed description of appli-
cations and recent developments in LCA appear elsewhere [26–30]. LCA was applied to three
sequential parts of the CIDI depression module: 1) The initial screening items, 2) Additional
duration and severity exclusion criteria, and 3) The core symptom questions. After each of
these parts, exclusion criteria expel respondents from the remainder of the diagnostic inter-
view, rendering a diagnosis of “not depressed”. Latent class models were fit to each of the three
parts in each of the four countries, and model fit was assessed using overall chi-square values
and Pearson standardized residuals. We chose not to rely on the chi-square test for Part 1
because, in general, large sample sizes will cause most chi-square-based statistics to almost
always report a statistically significant difference between observed data and model expecta-
tions, which suggests model misfit even for a well fitting model. Given the sample size for part
one (n~20,000) because no participants have yet been screened out of the module at that point,
we rely on residuals to judge model fit rather than chi-square.
Models in which less than 10% of the response pattern residuals were greater than |3| were
deemed well-fitting models.
Model selection in Part 1 was limited by the number of parameters. The four dichotomous
indicators would only allow for a two class model to be identified [31]. However, because this
part of the module (the initial screening questions) excluded a large number of individuals, we
wanted to explore additional heterogeneity that may not have been captured in the diagnostic
algorithm. We opted, therefore, to use a restricted three-class model in which one class con-
tained those who did not endorse the duration criteria, and the other two classes contained
Fig 1. CIDI depression items comprising the three parts of the latent transition model.
https://doi.org/10.1371/journal.pone.0198429.g001
The impact of measurement differences on cross-country depression prevalence estimates
PLOS ONE | https://doi.org/10.1371/journal.pone.0198429 June 7, 2018 5 / 14
respondents who endorsed one or more screening questions as well as the duration criteria.
This restriction created a class that was excluded from the rest of the module in a way that was
consistent with the algorithm, i.e. everyone in that class failed to endorse the required duration
criteria. For Part 2 (severity and length of episode questions), a similar restriction was placed
on a three-class model: one class contained those who did not endorse the episode duration
criteria, and the other two classes contained respondents endorsing degrees of severity in addi-
tion to the required duration of episodes.
As in part 1, this restriction simultaneously enhanced consistency with the diagnostic algo-
rithm (by creating a class that was excluded by not endorsing the diagnostic criterion of dura-
tion) while allowing us to explore additional heterogeneity among those respondents not
excluded.
A two-class model was selected for part 3—depressed and not depressed. Because the num-
ber of questions allowed for a more exploratory analysis of class structure in Part 3, multiple
indices were examined to select a model. The Bayesian Information Criteria (BIC) was used, as
well as the log likelihood and Consistent Aikike Information criterion (CAIC) were also exam-
ined to assess an optimal number of classes.
Because we had a large enough sample size and because we approached the class enumeration
process with some prior latent class model criteria but also wanted to explore additional hetero-
geneity in the data, we carried out a double split-half validation procedure to assure that the
selected models were consistent with the data. Each country’s dataset was first randomly split in
half. The class enumeration procedure described above was then conducted on each half of the
data separately in each country. The selected latent class model from each half was then fit to the
other half of the data, with the threshold parameters and the class-specific item response proba-
bility parameters constrained to the values of the parameters in the model from the opposite
half. If the model fit of this constrained model was not significantly worse than an unconstrained
model for a given half of the data, this indicated that the selected model reflected real heteroge-
neity in the data and not sample-specific variation, strengthening our confidence in the model.
This split half class enumeration and cross-validation procedure was carried out separately with
the samples from each of the four countries for each of the three parts of the data.
Latent transition model
In each of the four countries, a latent transition (LT) model was then specified as described in
Scorza et al 2015 [32], with transitions estimated separately between part 1 and part 2 and part
2 and part 3. This was done in each country allowing all parameters to vary between countries.
In order to reliably recover the LCA measurement parameter estimates from the separate
LCA measurement models for each part of the module, in the LT model we used random start
values for those parameters set equal to the maximum likelihood estimates from the separate
part LCAs. Transition restrictions were placed on the LTAs such that individuals who were
excluded from the remainder of the module were forced into a “catch” class, so that individuals
not contributing information to the module would not influence class structure and transition
probabilities. Other transition probabilities were allowed to be freely estimated in each coun-
try. Transition probability matrices for parts 1–2 and 2–3 were then multiplied to arrive at
transition probabilities from part 1 to part 3 of the module in each country. To estimate
depression prevalence in each country, the percentages of individuals in class 3 in part 1 (those
who endorsed initial symptom and duration criteria) were multiplied with their conditional
probabilities of transitioning to class 2, the “depressed” class, in Part 3. This product was the
initial estimate of prevalence. This LT estimate of depression was compared with the estimates
based on a straight application of the DSM algorithm.
The impact of measurement differences on cross-country depression prevalence estimates
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All models are estimated using the Mplus statistical software package, version 6.0 [33],
which allows for the use of random start value perturbations to guard against the algorithm
converging to local optima. Complex sampling designs were taken into account- cluster, strata,
and individual sampling weights were included in the estimation using the type = complex
with estimator = MLR command. This estimation process produces standard errors and chi-
square test statistics that are robust to non-normality [34] and standard errors adjusted for
non-independence of observations due to clustering, with a post-hoc sandwich estimator.
Individual country weights were re-scaled such that their weight in the pooled sample from all
four countries was proportional to the relative sample size of the country.
Results
Latent class model selection
In each part of the CIDI module, the same latent class model fit the data for each of the four
countries. Pearson standardized residuals for observed response patterns indicated good over-
all fit for the models. All models had less than 10% of the response pattern residuals greater
than |3| with the exception of the model for Part 1 in New Zealand, which had 21% of response
pattern residuals |3|, however, no response pattern residuals were>|4|. Chi-square p-values
were< .01 for all models in Part 1, which we assume is due to the very large sample sizes in the
datasets in this part. Chi-square p-values were 1 for all models in Parts 2 and 3, which have
smaller, but still large sample sizes, indicating good fit of the models to the data. The split half
validation procedure indicated that the selected model reflected real heterogeneity in the data
and not sample-specific variation of this constrained model, given that models selected from
one half of the data were not significantly worse fitting than an unconstrained model for the
other half of the data, Parts 1–3 in each country. Fit indices for the 2-class model in Part 3 are
provided in Table 1. While latent classes need not be ordered, the classes in each country in
the three parts do seem to correspond to levels of depression (See Fig 2). Thus while the
response probabilities of certain items are different by country, the overall pattern is ordered
classes based on likelihood of endorsing depression criteria, which can also be considered
depression severity. Relative entropy, a diagnostic index of an LC model’s classification preci-
sion, is also shown in Fig 1. Entropy measures posterior classification uncertainty and is
bounded between 0 and 1, with 1 being perfect classification precision [35].
Latent transition classification
In Nigeria, prevalence based on the LTA estimate was seven times higher than the estimate
based on the DSM algorithm along. Similarly in South Africa, the LTA estimate was one and a
half times higher than the estimate based on just the DSM algorithm. On the other hand, in
the US and New Zealand the LTA estimates were approximately the same as the DSM algo-
rithm diagnosis. A table of estimates across countries and classification methods is shown in
Table 2. Transition probabilities varied between countries, as displayed in Tables 3–5. In South
Africa, individuals in class 2 in part 1 were more likely to transition to the more severe class in
part 2, as compared with those in the other countries. Individuals in the most severe class in
part 1 in Nigeria were much more likely to be in the more severe class in part 2 compared with
the other countries. These two differences contribute to the large shifts in prevalence estimates
in Nigeria and South Africa from those based on the DSM algorithm to those based on the
LTA.
A result of different transition probabilities across countries, prevalence estimates based on
the LT model changes the order of depression prevalence across countries. Based on the DSM
algorithm, Nigeria has by far the lowest prevalence (3.1%), followed by South Africa (9.8%),
The impact of measurement differences on cross-country depression prevalence estimates
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then the United States (13.5%) and finally New Zealand (17.8%). Based on the LT model, Nige-
ria has the highest prevalence, followed by South Africa, then New Zealand, and finally the US.
In addition, the range of depression prevalence between countries is much narrower based on
the LT model than it is according to the DSM algorithm. The estimates based on the LT transi-
tion span from 15% in South Africa to 21.6% in Nigeria, a range of only 6 percentage points,
whereas the range of prevalence estimates based on the DSM algorithm spans from 3.1% in
Nigeria to 17.8% in New Zealand, a spread of over 14 percentage points.
Discussion
This analysis found that depression prevalence estimates across four countries- the United
States, New Zealand, South Africa and Nigeria- were markedly different when using a model
that allows for the possibility that participants respond differently across countries (the LTA)
as compared with one that does not (straight application of the DSM algorithm). Using the
LTA, the range of prevalence estimates was narrower across the four countries and the two
Table 1. Fit indices comparing models with 2 through 6 classes in part 3 in four countries.
SOUTH AFRICA
n = 309
# Classes LL Chi-2 p-value BIC CAIC
2 -1409.401 1 2939.202167 2960.202167
3 -1394.785 1 2973.036921 3005.036921
4 -1383.883 1 3014.299675 3057.299675
5 -1372.709 1 3055.018429 3109.018429
6 -1362.652 1 3097.971183 3162.971183
NIGERIA
n = 161
# Classes LL Chi-2 p-value BIC CAIC
2 -802.731 1 1712.171492 1733.171492
3 -787.486 1 1737.57694 1769.57694
4 -773.375 1 1765.250388 1808.250388
5 -764.289 1 1802.973836 1856.973836
6 -754.947 1 1840.185284 1905.185284
USA
n = 1898
# Classes LL Chi-2 p-value BIC CAIC
2 -7950.452 1 16059.42368 16028.61349
3 -7880.642 1 16002.83779 15955.88894
4 -7847.658 1 16019.90391 15956.81639
5 -7825.67 1 16058.96202 15979.73584
6 -7805.318 1 16101.29214 16005.92728
NEW ZEALAND
n = 1513
# Classes LL Chi-2 p-value BIC CAIC
2 -6657.605 1 13468.9711 17075.16884
3 -6619.053 1 13472.40519 17092.27919
4 -6600.338 1 13515.51554 17124.11954
5 -6577.317 1 13550.01388 17154.51588
6 -6557.436 1 13590.79223 17191.50423
https://doi.org/10.1371/journal.pone.0198429.t001
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Fig 2. Class-specific item endorsement probabilities for LCA model for each part of the module in four countries.
Note. Percentages of country samples that are in each class, based on posterior class probabilities, are given in the
legends. Entropy (E) is also displayed below the legend.
https://doi.org/10.1371/journal.pone.0198429.g002
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sub-Saharan African countries had higher prevalence than the United States and New Zealand.
Nigeria had the highest prevalence of the four countries when using LTA, while it had the low-
est prevalence when using the DSM algorithm alone, and the adjusted difference in prevalence
was sevenfold. This finding substantiates skepticism expressed about the accuracy of low levels
of depression in Nigeria found in the WMH Surveys (3.1% lifetime prevalence) [17]. Nigeria is
one of only two countries represented in the WMH surveys from sub Saharan Africa, so its
estimate of depression represents an important contribution to the global epidemiology of
depression.
Large differences were found between the four countries in the reporting of screening ques-
tions and impairment and duration criteria. Individuals in the two African countries in this
study- South Africa and Nigeria- were much less likely to endorse the duration criteria given
the same latent class.
Alegria et al. have suggested that screening items might be improperly excluding some indi-
viduals from diagnosis in structured diagnostic interviews when used in cross-cultural settings
[36]. Yet published validation exercises involving the CIDI have been completed almost
entirely in western countries; hence its cross-cultural reliability and validity remain unclear
[6,17]. The results show that the impact of these measurement differences on prevalence esti-
mates may be substantial.
Estimates of depression from epidemiologic studies such as the WMH Surveys are particu-
larly important given that these estimates are being used, among other data sources, to esti-
mate depression prevalence and disease burden globally [15]. In addition to using the actual
prevalence estimates from CIDI data, structured diagnostic interviews like the CIDI are being
used as gold standards on which adjustments to estimates from data using screening tools are
based [15]. Information on these adjustments is not transparent in the GBD study, but the
results of these analyses suggest that the measurement error, if not taken into account, could
affect GBD estimates greatly. GBD estimates, in turn, are being used in models estimating the
cost-effectiveness of mental health programs globally [4].
Table 2. Depression prevalence estimates across countries by algorithm and latent transition.
United States New Zealand South Africa Nigeria
DSM Algorithm 13.50% 17.80% 9.80% 3.10%
LTA 12.50% 17.40% 15.00% 21.60%
https://doi.org/10.1371/journal.pone.0198429.t002
Table 3. Latent transition probabilities across four countries for part 1 to part 2.
USA n = 19734 NZ n = 12816
Part 2 Part 2
Catch C1 C2 C3 Catch C1 C2 C3
Part 1 C1 1 0 0 0 Part 1 C1 1 0 0 0
C2 0 .113 .814 .073 C2 0 .185 .760 .055
C3 0 0 .350 .650 C3 0 0 .436 .564
SA N = 3947 Nigeria N = 6543
Part 2 Part 2
Catch C1 C2 C3 Catch C1 C2 C3
Part 1 C1 1 0 0 0 Part 1 C1 1 0 0 0
C2 0 .205 .669 .126 C2 0 .288 .628 .085
C3 0 0 .471 .529 C3 0 0 .060 .940
https://doi.org/10.1371/journal.pone.0198429.t003
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Several limitations should be mentioned. A fundamental concern with the LTA could be
that the classes of depression, freely estimated across countries in the LTA, could have different
practical and clinical meanings across countries. The meaning of depression categories across
cultures is an interesting area that merits further research that blends latent variable measure-
ment invariance analyses with qualitative research to understand local perceptions of the
importance of classifications of depression in different contexts. Future analyses using latent
classification methods could also use exogenous variables, such as functional impairment, to
assess the meaning and comparability of classification across countries. Depending on how
they are measured, however, these external variables might also have cross-cultural measure-
ment non-invariance, making their use not unproblematic.
Finally, it should be reiterated that not all differences in prevalence between countries are
likely due to measurement differences. As noted by Gureje et al., the age distribution of
respondents in different surveys may be a factor. In Nigeria, for example, the majority of the
WMH Survey respondents in the country’s survey were younger than the median age of onset
of the depression. [37] Indeed, another study in Nigeria found high rates of both prevalence
and incidence were reported among elderly persons, aged 65 years and over, in the commu-
nity. [38] The results of this current study are not meant to suggest that a uniformly similar
prevalence would indicate validity of surveys for mental disorders. The results do suggest,
Table 5. Latent transition probabilities across four countries for part 1 to part 3.
USA n = 19734 NZ n = 12816
Part 3 Part 3
Catch C1 C2 Catch C1 C2
Part 1 C1 1 0 0 Part 1 C1 1 0 0
C2 .113 .519 .368 C2 .185 .532 .292
C3 0 .223 .778a C3 0 .343 .657a
SA n = 3947 Nigeria n = 6543
Part 3 Part 3
Catch C1 C2 Catch C1 C2
Part 1 C1 1 0 0 Part 1 C1 1 0 0
C2 0 .205 .430 C2 .288 .358 .355
C3 0 0 .366a C3 0 .112 .888a
aShaded cells are those that constitute the latent transition depression diagnosis probabilities.
https://doi.org/10.1371/journal.pone.0198429.t005
Table 4. Latent transition probabilities across four countries for part 2 to part 3.
USA n = 4461 NZ n = 3431
Part 3 Part 3
Catch C1 C2 Catch C1 C2
Part 2 C1 1 0 0 Part 2 C1 1 0 0
C2 0 .638 .362 C2 0 .682 .318
C3 0 0 1 C3 0 .081 .919
SA N = 1286 Nigeria N = 812
Part 3 Part 3
Catch C1 C2 Catch C1 C2
Part 2 C1 1 0 0 Part 2 C1 1 0 0
C2 0 .615 .385 C2 0 .558 .442
C3 0 .145 .855 C3 0 .084 .916
https://doi.org/10.1371/journal.pone.0198429.t004
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however, that a non-insignificant portion of the differences are likely due to measurement
non-invariance across countries.
Above all, the analysis in this paper suggests that prevalence estimates from structured diag-
nostic interviews in radically different settings where measurement properties of tools have
not been thoroughly assessed, should not be used uncritically. The data available in the WMH
survey provide rich opportunities for understanding cross-cultural measurement of mental
disorders more comprehensively. The findings in this paper aim to stimulate more in-depth
research on measurement differences. When such a body of research is developed, the field of
global mental health will be better positioned to both modify tools for future studies and to use
adjusted prevalence estimates from current data sources in cost-effectiveness analyses and
resource allocation decisions.
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